Company intelligence / Profile preview
XYON Health
- Ownership
- Private
- Employees
- ~27
- Development stage
- Other
Overview
XYON Health has commercialized prescription and over-the-counter topical solutions for male-pattern hair loss using its proprietary SiloxysSystem™ gel technology. The company claims improved efficacy and reduced systemic side effects compared to oral therapies. Early clinical results are not detailed publicly but the company emphasizes science-backed innovation and ongoing physician support.
- Therapeutic areas
- Dermatology
- Modalities
- Small molecule (e.g., finasteride)Topical gel formulationPlant-based/natural ingredients (for OTC products)Biologic (potentially for future pipeline; not explicitly stated)
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on XYON Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on XYON Health.